欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1530/002
药品名称
Hydroxyzine Bluefish
活性成分
Hydroxyzine hydrochloride 25.0 mg
剂型
Film-coated tablet
上市许可持有人
Bluefish Pharmaceuticals AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Hydroxyzin Bluefish 25 mg Filmtabletten
Denmark (DK)
Iceland (IS)
Hydroxyzine Bluefish 25 mg Filmuhúðuð tafla
United Kingdom (Northern Ireland) (XI)
Spain (ES)
Norway (NO)
Hydroxyzine Bluefish
Poland (PL)
Hydroxyzine Bluefish
France (FR)
Portugal (PT)
许可日期
2016/02/22
最近更新日期
2024/12/12
药物ATC编码
N05BB01 hydroxyzine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
SE_H_1530_002_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1530_002_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase